Garza v. Davis

CourtCourt of Appeals for the Fifth Circuit
DecidedJanuary 7, 2022
Docket20-20533
StatusUnpublished

This text of Garza v. Davis (Garza v. Davis) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Garza v. Davis, (5th Cir. 2022).

Opinion

Case: 20-20533 Document: 00516158826 Page: 1 Date Filed: 01/07/2022

United States Court of Appeals for the Fifth Circuit United States Court of Appeals Fifth Circuit

FILED January 7, 2022 No. 20-20533 Lyle W. Cayce Summary Calendar Clerk

David Garza,

Plaintiff—Appellant,

versus

Lorie Davis; Troy Selman, Warden; Betty Williams, Medical Doctor,

Defendants—Appellees.

Appeal from the United States District Court for the Southern District of Texas No. 4:18-CV-4387

Before Smith, Stewart, and Graves, Circuit Judges. Per Curiam:*

David Garza, Texas inmate #1633521, appeals the summary-judgment dismissal of his 42 U.S.C. § 1983 civil action alleging that the defendants were deliberately indifferent to his serious medical needs by denying him proper

* Pursuant to 5th Circuit Rule 47.5, the court has determined that this opin- ion should not be published and is not precedent except under the limited circumstances set forth in 5th Circuit Rule 47.5.4. Case: 20-20533 Document: 00516158826 Page: 2 Date Filed: 01/07/2022

No. 20-20533

medication to manage his chronic pain. Garza further challenges the denials of his motion to amend and supplement his complaint and his motion for appointment of counsel. We affirm. The district court did not err by granting summary judgment. See McFaul v. Valenzuela, 684 F.3d 564, 571 (5th Cir. 2012). The competent summary judgment evidence shows that Dr. Williams prescribed Garza a 30-day course of naproxen—the pain medication he specifically requested— with no refills and warned him about risks of long-term use of naproxen that were specific to his underlying health conditions. The evidence also shows that Garza was prescribed two other medications for pain management—one with multiple refills—and also had access to acetaminophen by request. Accordingly, the district court properly determined that there is no genuine dispute of material fact and that Dr. Williams is entitled to judgment as a matter of law. See Fed. R. Civ. P. 56(a); Gobert v. Caldwell, 463 F.3d 339, 345-46 (5th Cir. 2006). Furthermore, Garza has waived, by failure to brief, any challenge to the summary judgment for the remaining defendants. See Grant v. Cuellar, 59 F.3d 523, 524 (5th Cir. 1995); Brinkmann v. Dallas Cnty. Deputy Sheriff Abner, 813 F.2d 744, 748 (5th Cir. 1987). Additionally, Garza fails to show an abuse of discretion in the denial of his motions to amend and supplement his complaint. See Pervasive Soft- ware Inc. v. Lexware GmbH & Co. KG, 688 F.3d 214, 232 (5th Cir. 2012); Burns v. Exxon Corp., 158 F.3d 336, 343 (5th Cir. 1998). He also does not demonstrate that the district court abused its discretion in declining to appoint counsel. See Baranowski v. Hart, 486 F.3d 112, 126 (5th Cir. 2007). AFFIRMED.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Grant v. Cuellar
59 F.3d 523 (Fifth Circuit, 1995)
Burns v. Exxon Corporation
158 F.3d 336 (Fifth Circuit, 1998)
Gobert v. Caldwell
463 F.3d 339 (Fifth Circuit, 2006)
Baranowski v. Hart
486 F.3d 112 (Fifth Circuit, 2007)
Anson McFaul v. Daniel Valenzuela
684 F.3d 564 (Fifth Circuit, 2012)
Pervasive Software, Inc. v. Lexware GMBH & Co. KG
688 F.3d 214 (Fifth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Garza v. Davis, Counsel Stack Legal Research, https://law.counselstack.com/opinion/garza-v-davis-ca5-2022.